J Pediatr Intensive Care 2022; 11(04): 355-358
DOI: 10.1055/s-0041-1731022
Letter to the Editor

Inborn Errors of Metabolism in Pediatric Intensive Care Unit: Much More to Understand

Puspraj Awasthi
1   Divisions of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
,
1   Divisions of Pediatric Critical Care, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
› Author Affiliations

We read with interest the recently published article titled “Inborn Errors of Metabolism in a Tertiary Pediatric Intensive Care Unit” by Lipari et al[1] and want to make few important comments. Authors enrolled 65 cases of inborn errors of metabolism (IEMs) with 88 admission to a pediatric intensive care unit (PICU) in Portugal over a period 11 years (2009–2019) accounting for 2% of PICU admissions. The children with intoxication disorders, energy metabolism defects, complex molecules, and other disorders accounted for 35.4% (n = 23), 32.3% (n = 21), 26.2% (n = 17), and 6.1% (n = 4), respectively. The median age at admission to PICU was 3 years (range: 3 days–21 years) and 70.4% (n = 62) admissions were for metabolic decompensation and 29.5% (n = 26) were elective/scheduled surgery/procedure admissions. The reasons for decompensation included infections (55.4%, n = 36) and metabolic stress during neonatal period (18.7%, n = 12). The common clinical presentations were respiratory failure (34.1%, 30/88) and neurological deterioration (29.5%, 26/88). The treatment included mechanical ventilation (n = 30), continuous venovenous hemodiafiltration (CVVHDF) (n = 16), specific nutritional management, and supportive care. The median duration of PICU stay was 3.6 days (range: 3 hours–35 days) and mortality was 12.3% (n = 8). The comparison of cases with intoxication disorders, energy metabolism defects, and complex molecules disorders is depicted in [Table 1]. Children with intoxication disorders constituted one-third of cases (35.4%), diagnosed early (median: 6 days of life), and had lowest median age at PICU admission (1.5 years). Although one-third cases with intoxication disorders had neonatal diagnosis (32.2%), only 65.2% were diagnosed before PICU admission and among 34.8% cases, the diagnosis was made after PICU admission. The higher proportion of children with intoxication disorders presented with coma (30.3%), required mechanical ventilation (9/31), CVVHDF (n = 14) (p < 0.0001), had longest PICU stay, and highest mortality (17.3%, n = 4) (p < 0.0001).

Table 1

Clinical characteristics, complications, treatment, and outcome among patients in different groups of IEMs admitted to a PICU

Characteristics

Total cases

Intoxication disorders

Energy metabolism defects

Complex molecules disorders

Number of cases

65

23 (35.4%)

21 (32.3%)

17 (26.2%)

Number of admissions

88

31

Neonatal diagnosis

20/65 (30.7%)

10/23 (43.5%)

6/21 (28.6%)

Median age at diagnosis

3 mo

(3 d–9 y)

6 d

12 mo

(6 d–3.5 y)

21 months

(1 mo–2.5 y)

Diagnosed before PICU admission

54/65 (83.1%)

15/23 (65.2%)

19/21 (90.4%)

15/17 (88.2%)

Neonatal admissions

14/88 (15.9%)

10/31 (32.2%)

2/21 (9.5%)

0

Median age at PICU admission

3 y (3 d–21 y)

1.5 y (3 d–12 mo)

3 y (14d–21 y)

3 y (3.5 mo–16 y)

Males

33

Admission reasons

 Metabolic decompensation

62/88 (70.4%)

 Elective (elective or scheduled surgery)

26/88 (29.5%)

Reason of decompensation

 Infection

36 (55.4%)

13/31 (41.9%)

11/21 (52.4%)

11/17 (64.7%)

 Metabolic stress during neonatal period

12 (18.5%)

11/31 (35.5%)

1 (4.3%)

0

Presentation

 Respiratory failure

30/88 (34.1%)

4/31 (12.9%)

4/21 (19%)

12/17 (70.6%)

 Neurological deterioration

26/88 (29.5%)

 Coma

15 (23.1%)

10/31 (30.3%)

4/21 (19%)

1/17 (5.9%)

 Lethargy with or without dehydration

10 (15.4%)

5 (21.7%)

5 (23.8%)

0

Complications

 Neurological repercussions

7/31

 Seizures

12 (18.5%)

4 (17.4%)

2 (9.5%)

6 (35.3%)

 Abnormal neuroimaging

5/31

2

 Coagulopathy

5/31

2

 Cardiac abnormalities

1

3

7

Treatment

 Concentrated dextrose

21 (100%)

 Respiratory support

11/31

 Invasive mechanical ventilation

30

9/31

5

11

 Parenteral nutrition

6

 CVVHDF

16

14

1

0

 Mortality

8 (12.3%)

4/23 (17.3%)

1/21 (4.8%)

2/17 (11.8%)

 PICU stay

3.6 d

(3 h–35 d)

2 (1–16) d

1 (1–19) d

1 (1–35) d

Abbreviations: CVVHDF, continuous venovenous hemodiafiltration; IEM, inborn errors of metabolism; PICU, pediatric intensive care unit.


Authors did a commendable job in highlighting the intensive care course and outcome of children with IEMs.[1] We would like to highlight few points pertinent to our setting. In developing countries like India, there is lack of universal neonatal testing for IEMs. In addition, the testing facilities for IEMs (tandem mass spectrometery, gas chromatography mass spectrometry, and molecular tests) are not available at all the cities and centers. A general understanding among pediatricians and physicians that the IEMs are rare compounded the issue of missed opportunity for diagnosis, inappropriate treatment, and poor outcome. Also, there is lack of well-designed large-scale studies from PICUs in India highlighting the intensive care needs and outcome of children with IEMs. A few small studies highlighted the profile and outcome of children with IEMs admitted to PICUs.[2] [3] These studies showed that children with IEMs constituted 0.9 to 2.6% of PICU admissions. The median age at presentation was 7 to 15 months. In one study, diagnosis was established in 80% cases before admission to PICU,[3] whereas in another study, none of the cases had diagnosis prior to the PICU admission.[2] This highlights the lack of universal neonatal testing for IEMs in India. The mortality was 33 to 36%[2] [3] that is much higher than the study by Lipari et al[1] highlighting late presentation, late diagnosis, and possibly lack of extracorporeal therapies in Indian PICUs.

The diagnosis of IEMs is not rare and IEMs contribute significantly to the global child mortality and morbidity.[4] [5] There is need to adopt universal neonatal screening program for common IEMs, facilities to diagnose IEMs at major centers, prenatal diagnosis, and specialized units to manage these cases to limit the burden of IEMs. In majority of infants and children, the diagnosis is usually not established prior to PICU admission in Indian setting. Therefore, to diagnose IEMs in PICU, intensivists should keep a high index of suspicion. Children admitted o PICU with IEMs require aggressive treatment in form of mechanical ventilation, extracorporeal therapies, nutritional modifications, and supportive care. In view of paucity of literature from developing countries, there is need of large multicentric studies on the profile, intensive care needs, and outcomes in children with IEM admitted to PICUs.



Publication History

Received: 11 March 2021

Accepted: 16 April 2021

Article published online:
26 June 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Lipari P, Shchomak Z, Boto L. et al. Inborn errors of metabolism in a tertiary pediatric intensive care unit. J Pediatr Intensive Care 2020; DOI: 10.1055/s-0040-1721738.
  • 2 Kamate M, Chetal V, Kulgod V, Patil V, Christopher R. Profile of inborn errors of metabolism in a tertiary care centre PICU. Indian J Pediatr 2010; 77 (01) 57-60
  • 3 Sivaraman RP, Balakrishnan U, Chidhambaram S, Tarikare S, Sankaranarayanan S. Profile and outcome of children with inborn errors of metabolism in a tertiary pediatric intensive care unit in South India. Indian J Child Health (Bhopal) 2019; 6: 104-109
  • 4 Waters D, Adeloye D, Woolham D, Wastnedge E, Patel S, Rudan I. Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence. J Glob Health 2018; 8 (02) 021102
  • 5 Jouvet P, Touati G, Lesage F. et al. Impact of inborn errors of metabolism on admission and mortality in a pediatric intensive care unit. Eur J Pediatr 2007; 166 (05) 461-465